ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $960,694 | +98.5% | 44,303 | +77.5% | 0.00% | 0.0% |
| Q3 2022 | $484,000 | +14.2% | 24,962 | +17.0% | 0.00% | 0.0% |
| Q2 2022 | $424,000 | -30.0% | 21,330 | +5.1% | 0.00% | -33.3% |
| Q1 2022 | $606,000 | +156.8% | 20,300 | +100.0% | 0.00% | +200.0% |
| Q4 2021 | $236,000 | -21.1% | 10,150 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $299,000 | -11.5% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $338,000 | 0.0% | 9,596 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $338,000 | -8.6% | 9,596 | -2.8% | 0.00% | -50.0% |
| Q4 2020 | $370,000 | +12.5% | 9,869 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $329,000 | +26.1% | 9,869 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $261,000 | +29.2% | 9,869 | +24.1% | 0.00% | 0.0% |
| Q4 2019 | $202,000 | +0.5% | 7,951 | +27.7% | 0.00% | 0.0% |
| Q1 2019 | $201,000 | – | 6,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 480,000 | $14,318,000 | 9.25% |
| Decheng Capital Management III (Cayman), LLC | 518,342 | $15,462,000 | 4.74% |
| TANG CAPITAL MANAGEMENT LLC | 467,702 | $13,952,000 | 2.79% |
| Birchview Capital, LP | 113,000 | $3,371,000 | 2.43% |
| Privium Fund Management B.V. | 351,805 | $10,494,000 | 2.32% |
| Sio Capital Management, LLC | 144,546 | $4,312,000 | 1.43% |
| Perceptive Advisors | 2,360,139 | $70,403,000 | 1.41% |
| Chicago Capital, LLC | 1,011,744 | $30,180,000 | 1.30% |
| Endurant Capital Management LP | 120,834 | $3,604,000 | 0.95% |
| Nicholas Investment Partners, LP | 439,235 | $13,102,000 | 0.93% |